FASLG Human, HEK

FAS Ligand Human Recombinant, HEK
Cat. No.
BT22629
Source
HEK293 cells.
Synonyms
Fas ligand (TNF superfamily, member 6), APT1LG1, FASL, TNFSF6, CD178, tumor necrosis factor (ligand) superfamily member 6, Apoptosis antigen ligand, Fas antigen ligand, APTL, CD95-L.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by:
(a) Analysis by SEC-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Human FAS Ligand produced in HEK293 cells is a polypeptide chain containing 147 amino acids (134-281a.a).
FASLG is fused to a 6 amino acid His-tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
FASLG, a type II transmembrane protein, belongs to the tumor necrosis factor (TNF) superfamily and plays a crucial role in immune system regulation and cancer development. This protein is found on activated T cells as a non-disulfide-linked homotrimer. Upon binding to Fas/CD95/TNFRSF6 on adjacent cells, FASLG triggers apoptosis. Metalloproteinases facilitate the release of FASLG from the cell surface as a soluble, trimeric molecule. While this soluble form retains its Fas-binding ability, its apoptosis-inducing capacity is significantly diminished. Additionally, FASLG interacts with DcR3, a soluble decoy receptor lacking signal transduction capabilities. Impaired Fas-mediated apoptosis contributes to oncogenesis and drug resistance in existing tumors. The constitutive expression of FASLG in various tumors enables them to evade immune surveillance. Both murine and human FASLG exhibit activity on cells from both species.
Description
Recombinant Human FAS Ligand, expressed in HEK293 cells, is a polypeptide chain comprising 147 amino acids (residues 134-281). It includes a 6-amino acid His-tag fused to the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
The FASLG solution has a concentration of 0.6 mg/ml and is prepared in 1xPBS.
Stability
For optimal stability, store FASLG Human Recombinant below -18°C. While it remains stable at 4°C for up to 1 week, repeated freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 95.0% using the following methods: (a) Size-exclusion high-performance liquid chromatography (SEC-HPLC) (b) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
Biological Activity
The biological activity of Fas ligand is assessed by its ability to induce cytotoxicity in Jurkat cells without the need for cross-linking. The anticipated ED₅₀ is less than 10 ng/ml, which corresponds to a specific activity of 1x10⁵ units/mg.
Synonyms
Fas ligand (TNF superfamily, member 6), APT1LG1, FASL, TNFSF6, CD178, tumor necrosis factor (ligand) superfamily member 6, Apoptosis antigen ligand, Fas antigen ligand, APTL, CD95-L.
Source
HEK293 cells.

Product Science Overview

Structure and Expression

FASLG is expressed on the surface of activated T cells and natural killer (NK) cells as a non-disulfide-linked homotrimer . The FASLG gene is located on human chromosome 1q24.3, spans 8 kb, and contains 4 exons . The protein is initially produced as a membrane-bound form but can be cleaved by metalloproteinases to release a soluble form .

Function

The primary function of FASLG is to induce apoptosis in cells expressing the FAS receptor (CD95/Apo-1) . This interaction is vital for maintaining immune system homeostasis, including activation-induced cell death, T-cell-induced cytotoxicity, immune privilege, and tumor surveillance . Additionally, FASLG has been implicated in non-apoptotic pathways, such as cell proliferation and NF-κB activation .

Recombinant Production

Recombinant human FAS Ligand (rHuFASL) is produced in HEK293 cells, a human embryonic kidney cell line . The recombinant protein is typically fused to a 6-amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques . The resulting product is a sterile filtered clear solution with a purity greater than 95%, as determined by SEC-HPLC and SDS-PAGE .

Applications

Recombinant FASLG is used extensively in research to study apoptosis and immune regulation. It is also employed in ligand binding assays and other biochemical applications . The recombinant protein is available in both membrane-bound and soluble forms, with the latter being less effective in inducing apoptosis .

Stability and Storage

The FASLG solution is stable at 4°C for one week but should be stored below -18°C for long-term use . It is important to avoid freeze-thaw cycles to maintain the protein’s integrity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.